← FDA Drug Approvals (Drugs@FDA)

TRIAMTERENE AND HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1993-09-23

Drug application

FDA Application #
ANDA073449
Application type
Abbreviated New Drug Application (Generic)
Brand name
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Generic name
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
WATSON LABS
Manufacturer
BluePoint Laboratories
First approval
1993-09-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown